title: Why do statins reduce cardiovascular disease more than other lipid modulating therapies?
authors.affiliation: Li Ka Shing Faculty of Medicine, School of Public Health, The University of Hong Kong, Hong Kong, China; City University New York School of Public Health and Hunter College, New York, NY, USA.
authors.forename: C Mary
authors.initials: CM
authors.lastname: Schooling
authors.forename: Shiu Lun
authors.initials: SL
authors.lastname: Au Yeung
authors.forename: Gabriel M
authors.initials: GM
authors.lastname: Leung
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents